@烟台人 华医康复医院运动康复门诊开诊啦！-今日推荐-今日推荐-水母网 shm.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shm.com.cn Daily Mail and Mail on Sunday newspapers.
CMS has increased the Medicare payment rate by $12 for administering single-dose Covid-19 vaccines and by $35 for two-dose vaccines. The payment increase aims to support providers as they ramp up vaccine administration.
The House of Representatives will vote this week on a bill to stop billions in automatic cuts to Medicare. GOP lawmakers who previously railed against the cuts are now silent on whether they ll back the legislative fix.
The bill is authored and co-sponsored by Democratic House committee chairs: Budget Committee Chair John Yarmuth, Agriculture Committee Chair David Scott, Energy and Commerce Committee Chair Frank Pallone, and Ways and Means Committee Chair Richard Neal. Not a single Republican has signed on as a co-sponsor so far.
Last week, Congressional Democrats passed the $1.9 trillion American Rescue Plan to help curb the coronavirus pandemic and fix the economic damage it has caused without a single Republican vote in favor.
(0)
Preliminary Data from Single-Ascending Dose Cohorts Expected Later this Year Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced that the company has initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study (Assessment of KAN-101 in Celiac Disease), a Phase 1 clinical trial evaluating KAN-101 for the treatment of individuals with celiac disease. Initiation of the MAD cohort enrollment follows completion of the first two single-ascending dose (SAD) cohorts in the trial, with the third SAD cohort actively dosing patients.
KAN-101, Anokion s lead antigen-specific drug product candidate, aims to re-educate immune cells to not respond to gluten antigens. The ACeD study is a randomized, double-blind, placebo-controlled Phase 1 trial that will enroll a total of up to 40 patients with celiac disease who are on a gluten free diet. The study is composed of two parts. In